
Thermo Fisher Scientific NKX2.2 Monoclonal Antibody (ZM14), MonoMab
Ready-to-use monoclonal antibody for IHC detection of NKX2.2 in formalin-fixed, paraffin-embedded tissues. Highly specific marker for Ewing sarcoma and neuroendocrine tumors. Mouse IgG1 clone ZM14, unconjugated form, stored at 4°C.
- 카탈로그번호
- Z2348MP
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific NKX2.2 Monoclonal Antibody (ZM14), MonoMab
Applications
- Immunohistochemistry (Paraffin) (IHC (P))
Tested Dilution
Ready-to-use (150–200 µL)
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Mouse / IgG1, kappa |
| Class | Monoclonal |
| Type | Antibody |
| Clone | ZM14 |
| Immunogen | Human recombinant NKX2.2 protein fragment (aa 1–119) |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification | Protein A |
| Storage buffer | Tris with BSA, NP-40 |
| Contains | <0.1% sodium azide |
| Storage conditions | 4°C |
| Shipping conditions | Wet ice |
Product Specific Information
This product is diluted and ready-to-use.
A recommended positive control tissue is Ewing’s sarcoma, though other positive controls may be used.
The antibody is intended for professional laboratory use in detecting NKX2.2 protein in formalin-fixed, paraffin-embedded tissue through manual qualitative immunohistochemistry (IHC). It is used after the primary diagnosis of tumor by conventional histopathology.
NKX2.2 expression is observed in neuroendocrine tumors of the gut and serves as a marker for gastrointestinal neuroendocrine tumors. It is also a target of the EWS-FLI-1 fusion protein specific to Ewing sarcoma, showing 93% sensitivity and 89% specificity, aiding in differential diagnosis of small round cell tumors.
Pretreatment of deparaffinized tissue with heat-induced or enzymatic epitope retrieval is recommended.
IHC staining involves sequential application of primary antibody, secondary antibody, enzyme complex, and chromogenic substrate, with washing steps between applications. The chromogen reaction produces visible staining at the antigen site, interpreted under a light microscope.
A positive tissue control must be included in each staining procedure. This control should contain both positive and negative staining regions and be processed identically to patient samples. Weak positive controls are preferred for detecting minor changes in antibody sensitivity or reagent stability.
Negative control tissue may be internal or external depending on institutional guidelines. Negative sites should show absence of specific staining, ensuring minimal background signal. If specific staining appears in negative controls, patient results are invalid.
Target Information
The NKX2.2 gene encodes a nuclear transcription factor containing a homeobox domain, involved in central nervous system morphogenesis. It is located on chromosome 20 near NKX2-4 and duplicated on chromosome 14 as TITF1 and NKX2-8.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
제품 이미지
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
